Request Sample Form


Phone No.*:


Service Intersted In:

Download Complete Report

Your Name*:


Contact Number*:


Service Interested In* (required)

Your Requirment*:

Fazer invests 10m euros in plant to convert oat hulls into xylitol

Finnish food company Fazer will build a €10.7 million facility in Finland capable of producing xylitol from oat hulls.

April 17th, 2019|News|

FrieslandCampina sells its Creamy Creation cream liqueur unit

FrieslandCampina has opted to offload its Creamy Creation cream liqueur manufacturing business to Wagram Equity Partners, a Dutch private investment company.

April 17th, 2019|News|

Big Changes May Be in Store for Alberta Energy Industry

Alberta returned to its conservative roots, electing United Conservative Party Leader Jason Kenney premier after he vowed to fight harder for the Canadian province’s beleaguered energy industry.

April 17th, 2019|News|

LifeArc licenses discovery programme to Daiichi Sankyo

LifeArc has announced the signing of a deal to license an ion channel drug discovery programme to Daiichi Sankyo.

April 17th, 2019|News|

New data reinforce effectiveness of Novartis’ Zolgensma for SMA

New AveXis data has reinforced the effectiveness of Novartis’ spinal muscular atrophy (SMA) Type I drug, Zolgensma (onasemnogene abeparvovec-xioi).

April 17th, 2019|News|

Rising plastic pollution

Researchers find evidence of rising plastic pollution in an accidental source: log books for plankton-monitoring instruments.

April 17th, 2019|News|

Pig brain partially revived hours after death

Revival of disembodied organs raises slew of ethical and legal questions about the nature of death and consciousness.

April 17th, 2019|News|

OPEC’s Production Cuts Success At Risk with $80 Oil

After managing to revive oil prices through production cutbacks, OPEC now risks squandering its victory again by letting crude surge too high.

April 16th, 2019|News|

EVENITY™ (romosozumab-aqqg) now available in the United States for the treatment of osteoporosis in postmenopausal women at high risk for fracture

Amgen (NASDAQ: AMGN) announced that EVENITY™ (romosozumab-aqqg) is now available for shipment to wholesalers in the U.S. EVENITY was approved by the U.S.

April 16th, 2019|News|

Fluid nourishing tumor cells

The substance that bathes tumors in the body is quite different from the medium used to grow cancer cells in the lab, biologists report.

April 16th, 2019|News|